D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 46 Citations 18,389 109 World Ranking 2553 National Ranking 58

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Bacteria
  • Internal medicine

His primary areas of study are Microbiology, Drug resistance, Antibiotic resistance, Antimicrobial susceptibility and Biotechnology. Microbiology is closely attributed to Bacteria in his research. The Drug resistance study combines topics in areas such as Antibiotics, Fosfomycin, Ceftolozane, Plazomicin and Escherichia coli.

His work focuses on many connections between Antibiotic resistance and other disciplines, such as Public health, that overlap with his field of interest in Absolute number and Disease. Gunnar Kahlmeter has researched Antimicrobial susceptibility in several fields, including Clinical microbiology, Horse blood and Mueller-Hinton agar. Gunnar Kahlmeter interconnects Pseudomonas aeruginosa, Multiple drug resistance, Enterococcus and Acinetobacter in the investigation of issues within Antimicrobial.

His most cited work include:

  • Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance (4863 citations)
  • Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis (1203 citations)
  • The global threat of antimicrobial resistance: science for intervention (486 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Microbiology, Antimicrobial susceptibility, Antibiotic resistance, Antibiotics and Antimicrobial. His Microbiology research incorporates elements of Staphylococcus aureus, Agar and Escherichia coli. His Antimicrobial susceptibility study incorporates themes from Clostridium difficile, Broth microdilution, Biotechnology and Computational biology.

His Antibiotic resistance research incorporates elements of Infection control, Virology, Environmental health, Public health and Drug resistance. His Antimicrobial research is multidisciplinary, incorporating perspectives in Inhibition zone and Intensive care medicine. His Klebsiella pneumoniae research includes themes of Pseudomonas aeruginosa, Colistin and Acinetobacter.

He most often published in these fields:

  • Microbiology (50.56%)
  • Antimicrobial susceptibility (20.00%)
  • Antibiotic resistance (18.89%)

What were the highlights of his more recent work (between 2017-2021)?

  • Microbiology (50.56%)
  • Antimicrobial susceptibility (20.00%)
  • Internal medicine (12.22%)

In recent papers he was focusing on the following fields of study:

Microbiology, Antimicrobial susceptibility, Internal medicine, Broth microdilution and Antimicrobial are his primary areas of study. The Microbiology study combines topics in areas such as Staphylococcus pseudintermedius, Mycobacterium tuberculosis complex, Methicillin resistance, Agar and Klebsiella pneumoniae. His study looks at the intersection of Mycobacterium tuberculosis complex and topics like Drug resistance with Antibiotic resistance.

His study in the fields of Retrospective cohort study under the domain of Internal medicine overlaps with other disciplines such as Safety studies. His Antimicrobial research is multidisciplinary, relying on both Test, Dosing regimen, Pharmacokinetics, Susceptibility testing and Drug. His studies deal with areas such as Pseudomonas aeruginosa and Acinetobacter as well as Agar plate.

Between 2017 and 2021, his most popular works were:

  • MIC-based dose adjustment: facts and fables. (115 citations)
  • Developmental roadmap for antimicrobial susceptibility testing systems (74 citations)
  • Clinical bacteriology in low-resource settings: today's solutions (56 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Bacteria
  • Internal medicine

His primary scientific interests are in Antimicrobial susceptibility, Microbiology, Antimicrobial, Internal medicine and Risk analysis. His Antimicrobial susceptibility study is concerned with the larger field of Antibiotic resistance. His Microbiology study typically links adjacent topics like Mycobacterium tuberculosis complex.

His Antimicrobial study combines topics from a wide range of disciplines, such as Pharmacokinetics, Therapeutic drug monitoring, Susceptibility testing and Intensive care medicine. Gunnar Kahlmeter has researched Internal medicine in several fields, including Amphotericin B, Itraconazole, Posaconazole, Colistin and Polymyxin. His Risk analysis study combines topics in areas such as Microbiological Techniques and Quality assurance.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

A-P Magiorakos;A Srinivasan;R B Carey;Y Carmeli.
Clinical Microbiology and Infection (2012)

7485 Citations

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Evelina Tacconelli;Elena Carrara;Alessia Savoldi;Stephan Harbarth.
Lancet Infectious Diseases (2017)

1669 Citations

The global threat of antimicrobial resistance: science for intervention

Ignasi Roca;Murat Akova;F. Baquero;Jean Carlet.
new microbes and new infections (2015)

777 Citations

EUCAST expert rules in antimicrobial susceptibility testing

R. Leclercq;R. Cantón;D.F.J. Brown;C.G. Giske.
Clinical Microbiology and Infection (2013)

605 Citations

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients

E. Tacconelli;M.A. Cataldo;S.J. Dancer;G. De Angelis.
Clinical Microbiology and Infection (2014)

559 Citations

Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories

E. Matuschek;D.F.J. Brown;G. Kahlmeter.
Clinical Microbiology and Infection (2014)

491 Citations

Aminoglycoside toxicity – a review of clinical studies published between 1975 and 1982

Gunnar Kahlmeter;Jörgen I. Dahlager.
Journal of Antimicrobial Chemotherapy (1984)

429 Citations

European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria

Gunnar Kahlmeter;Derek F. J. Brown;Fred W. Goldstein;Alasdair P. MacGowan.
Journal of Antimicrobial Chemotherapy (2003)

419 Citations

Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use

Ingo Klare;Carola Konstabel;Guido Werner;Geert Huys.
Journal of Antimicrobial Chemotherapy (2007)

374 Citations

Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values

J. Turnidge;G. Kahlmeter;G. Kronvall.
Clinical Microbiology and Infection (2006)

355 Citations

Best Scientists Citing Gunnar Kahlmeter

Christian G. Giske

Christian G. Giske

Karolinska University Hospital

Publications: 66

Antonio Oliver

Antonio Oliver

Instituto de Salud Carlos III

Publications: 66

Rafael Cantón

Rafael Cantón

Instituto Ramón y Cajal de Investigación Sanitaria

Publications: 63

Didier Raoult

Didier Raoult

Aix-Marseille University

Publications: 62

Johan W. Mouton

Johan W. Mouton

Erasmus University Rotterdam

Publications: 56

Jesús Rodríguez-Baño

Jesús Rodríguez-Baño

University of Seville

Publications: 56

Matthew E. Falagas

Matthew E. Falagas

Alfa Institute of Biomedical Sciences

Publications: 55

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 54

Luis Martínez-Martínez

Luis Martínez-Martínez

University of Córdoba

Publications: 54

Sharon J. Peacock

Sharon J. Peacock

University of Cambridge

Publications: 53

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 53

Jason A. Roberts

Jason A. Roberts

Royal Brisbane and Women's Hospital

Publications: 49

David L. Paterson

David L. Paterson

University of Queensland

Publications: 49

Robert K. Flamm

Robert K. Flamm

Janssen (Belgium)

Publications: 48

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 47

Álvaro Pascual

Álvaro Pascual

Spanish National Research Council

Publications: 47

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.